Skip to content

Women's Healthy Aging and Menopause; (WHAM)

A Feasibility Study Examining the Comparison of Transcendental Meditation Versus Health Education on Psychological and Hemodynamic Function in Post-menopausal Women

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07314827
Enrollment
60
Registered
2026-01-02
Start date
2026-10-01
Completion date
2028-01-31
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Education, Meditation

Brief summary

The present study will examine whether women at high risk for developing hypertension, i.e., post-menopausal status, at least mild psychological distress, and mildly elevated blood pressure, show improvements in these risk factors after a 12-week Transcendental Meditation (TM) intervention compared to Women's Health Education (WHE). Positive findings will provide initial evidence of using nonpharmacological methods, such as TM, to prevent hypertension in postmenopausal women.

Interventions

Orientation: 18-minute self-guided video; 30-45 minute remote group introductory talk. Instructional phase: 10-minute individual interview (phone/Zoom); one 60-75 minute in-person 1:1 TM instruction session at Miami TM Center, Lennar Center, or University of Miami (UM) Osher Center; three consecutive in-person group sessions (60-75 minutes each). Follow-up seminars: Six sessions over nine weeks (in person or Zoom), including a "10th Day Check" and additional \~30-minute seminars at 1, 2, and 3 months. Home practice: Two daily TM sessions (20 minutes each, morning and evening).

BEHAVIORALWomen's Health Education (WHE)

Stage 1: 30-minute video and introductory lecture on menopause and cardiovascular health. Stage 2: 60-minute one-on-one health coach meeting plus nutrition video. Stage 3: Eight sessions (\~30 minutes each) with health check-ins, materials, and videos covering physical activity for heart and bone health, sleep and stress management during menopause, and lifestyle goal review and planning.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. ≥130 systolic blood pressure (SBP) ≤160 and/or 84 ≥ diastolic blood pressure (DBP) ≤100. 2. Perceived stress scale (PSS-4) \> 5 3. Able to give informed consent. 4. Understand study procedures and comply with them for the length of the study. 5. Ages between 50 and 80 years. 6. Post-menopausal ≥ 1 year since last menstruation 7. Reads and speaks English 8. UHealth patients 9. Working at least part-time

Exclusion criteria

1. Currently in a meditation program. 2. Meditates more than once per week 3. Recent stroke or cerebral neurologic impairment. 4. Current uses of mood stabilizers or antipsychotics. 5. Has been diagnosed with bipolar disorder, schizophrenia, or substance use disorder. 6. Inability to give written informed consent in English.

Design outcomes

Primary

MeasureTime frameDescription
Recruitment feasibility-The number of individuals approached vs participate.up to 3 yearsRecruiters will record the numbers of individuals who agree to participate vs interested in hearing about the study.
Recruitment feasibility-Reasons for not participatingup to 3 yearsA checklist completed by recruiters (schedule, time commitment, topic, ineligible, other)
Attendance feasibility - Training sessions attended by TM and WHE group12 weeksTraining sessions attended by the TM participants as well as the attendance and participation in videos watched for the WHE group will be recorded.
Compliance feasibility - The number of meditation sessions per week for the TM participants.12 and 24 weeksParticipants in the TM group estimate in the last month how many days per week they meditated (0 = not at all, 1 = up to 3 days per week, 2 = nearly every day once per day, 3 = nearly every day twice per day)
Stress - Perceived Stress Scale-10 (PSS-10)Baseline, 8, 12, and 24 weeksValidated self-reporting instrument with 10 questions on perceived stress. Each question is rated on a 5-point Likert scale ranging from 0 = never to 4 = Very Often, referring to experiences in the past month. Total scores range from 0 to 40, higher = more stress.
Depressed mood - Patient Health Questionnaire-9, (PHQ-9)Baseline, 8, 12, and 24 weeksA 9-item self-report measure of depressive symptoms. Each question is rated on a scale of 0 to 3, based on how often the symptom has been experienced in the past two weeks (0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day). The total score ranges from 0 to 27, higher scores indicating more severe depression.
Anxiety - Generalized Anxiety Disorder-7, (GAD-7)Baseline, 8, 12, and 24 weeksA 7-item self-report questionnaire assessing symptoms of generalized anxiety disorder. Items are rated on a scale of 0-3 based on frequency over the past two weeks (0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day). The total score ranges from 0-21, with higher scores indicating more severe anxiety symptoms.
Pain - Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference and Pain IntensityBaseline, 8, 12, and 24 weeksPatient-reported outcomes from the PROMIS system. Pain Interference items assess the extent to which pain hampers daily activities, social, and emotional functioning. Pain Intensity is assessed with a 0-10 numeric rating scale for worst, average, and current pain. Higher scores indicate greater pain burden.
Menopausal Symptoms - Greene Climacteric Scale (GCS)Baseline, 8, 12, and 24 weeksA 21-item questionnaire assessing menopausal symptoms across four domains: psychological (anxiety/depression), somatic (aches, headaches), vasomotor (hot flashes, night sweats), and sexual function. Each item is scored 0-3 (0 = Not at all, 3 = Extremely). Total and subscale scores indicate severity of menopausal symptoms.
Fruits and Vegetables IntakeBaseline, 8, 12, and 24 weeksA brief dietary assessment asking participants to report the average number of daily servings of fruits and vegetables consumed. Responses are recorded as number of servings per day.
24-hour Hemodynamic MonitoringBaseline and 12 weeksContinuous ambulatory monitoring using Bio-Beat patches and a Polar chest strap. Measures include systolic and diastolic blood pressure, and heart rate averaged over 24 hours. Provides objective cardiovascular data.

Secondary

MeasureTime frameDescription
Acceptability quantitative - Satisfaction with interventions12-weeks post interventionsSatisfaction with interventions Likert Scale (0-4, with 0 as not at all satisfied and 4 as extremely satisfied).
Acceptability qualitative - Strengths and weaknesses of the interventions12-weeks post interventionParticipants will be asked to write one to two sentences on the strengths and one to two sentences on the weaknesses of the intervention e.g., time commitment, travel to sites (TM group)
Mental Well-being - Warwick-Edinburgh Mental Well-being Scale (WEMWBS)Baseline, 8, 12, and 24 weeksA 14-item self-report scale assessing positive mental health and well-being. Each item is rated on a 5-point Likert scale from 1 = None of the time to 5 = All of the time, based on experiences over the past two weeks. Total scores range from 14-70, with higher scores reflecting greater well-being.
Insomnia - Insomnia Severity Index (ISI)Baseline, 8, 12, and 24 weeksA 7-item self-report measure assessing the nature, severity, and impact of insomnia. Each item is scored on a 0-4 scale (0 = No problem, 4 = Very severe problem) based on the previous two weeks. Total scores range from 0-28, with higher scores indicating more severe insomnia symptoms.
Primary Care Probable Post-Traumatic Stress Disorder (PTSD) Screen for Diagnostic and Statistical Manual for Mental Disorders (DSM-5) (PC-PTSD-5)Baseline, 8, 12, and 24 weeksA 5-item self-report screening tool for post-traumatic stress disorder. Respondents indicate whether they have been bothered by PTSD symptoms in the past month with a yes/no format. A cutoff of 3 or more positive responses suggests probable PTSD.
Brief Resilience Scale (BRS)Baseline, 8, 12, and 24 weeksA 6-item self-report questionnaire assessing the ability to bounce back or recover from stress. Each item is rated on a 5-point scale from 1 = Strongly disagree to 5 = Strongly agree. Scores are averaged, with higher scores reflecting greater resilience.
Leisure Time Exercise Questionnaire (LTEQ)Baseline, 8, 12, and 24 weeksA self-report questionnaire measuring the frequency of mild, moderate, and strenuous exercise during free time in a typical week. Frequencies are weighted by estimated metabolic equivalents (METs) and summed to yield a total exercise score.
Health Status and MedicationsBaseline, 8, 12, and 24 weeksParticipants self-report current health status and provide details on prescribed medications, including type, dosage, and frequency. This measure tracks changes in medication use over time.

Countries

United States

Contacts

CONTACTLaura Redwine, PhD
lss61@miami.edu305-243-5267
CONTACTJacqueline Allen-Magers, MS
jacqueline.am@miu.edu
PRINCIPAL_INVESTIGATOREdward R Schwartz, MD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026